v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows used in operating activities:    
Net income (loss) $ (25,028) $ 129,932
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 9,966 7,755
Stock-based compensation 18,546 17,440
Loss on disposal of property and equipment 0 31
Non-cash lease amortization 858 664
Amortization of capitalized commissions 538 0
Foreign currency gain/loss from remeasurement 791 (160)
Change in fair value of contingent acquisition liabilities (39,392) (176,100)
Change in fair value of derivative 2,491 (1,289)
Deferred income taxes 17 (1)
Other, net 744 903
Changes in operating assets and liabilities:    
Accounts receivable, net 1,542 2,347
Other current assets (767) (239)
Contract assets 1,261 5,816
Other non-current assets 548 (1,181)
Accounts payable (2,503) 1,151
Accrued liabilities 2,655 (8,403)
Contingent acquisition liabilities (1,335) 0
Other current liabilities (61) (581)
Operating lease liabilities (809) (836)
Deferred revenue 3,028 3,667
Other non-current liabilities 652 (101)
Net cash used in operating activities (26,258) (19,185)
Cash flows used in investing activities:    
Purchases of property and equipment (468) (162)
Capitalized software development costs (2,592) 0
Net cash used in investing activities (3,060) (162)
Cash flows provided by (used in) financing activities:    
Proceeds from sales of Class A common stock under the Second Equity Distribution Agreement 0 67,707
Proceeds from exercise of stock options and employee stock purchase plan 396 666
Proceeds from warrants exercised 0 13
Payment of financing costs associated with the Second Equity Distribution Agreement 0 (1,355)
Payment to settle contingent earnout liabilities (3,538) 0
Payments on finance leases (101) (21)
Net cash provided by (used in) financing activities (3,243) 67,010
Effects of exchange rate changes on cash (287) (94)
Net change in cash, cash equivalents, and restricted cash equivalents (32,848) 47,569
Cash, cash equivalents, and restricted cash equivalents, beginning of period 249,166 198,916
Cash, cash equivalents, and restricted cash equivalents, end of period 216,318 246,485
Reconciliation to amounts on the condensed consolidated balance sheets:    
Cash and cash equivalents 215,642 245,809
Non-current portion of restricted cash equivalents 676 676
Total cash, cash equivalents, and restricted cash equivalents shown in the condensed consolidated statements of cash flows 216,318 246,485
Supplemental disclosures of cash flow information:    
Cash paid for interest 15 2
Cash paid for income taxes, net 689 1,230
Noncash or Part Noncash Acquisitions [Line Items]    
Right-of-use assets obtained in exchange for lease liabilities 2,886 0
Deferred offering costs reclassified to additional paid-in capital 0 69
Stock-based compensation included in capitalized software development costs 918 0
Settle Contigent Holdback Consideration Of S Y N Q3 Acquisition Member    
Noncash or Part Noncash Acquisitions [Line Items]    
Issuance of Class A Common Stock to contingent earnout liabilities $ 2,028 $ 0